Agile Therapeutics | AGRX - Frais De Vente Et D'Administration



Frais De Vente Et D'Administration Changement Date
Adma Biologics USD 23.05M 320K 2025-09
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Bayer EUR 4.05B 647M 2025-12
BioMarin Pharmaceutical USD 322.21M 98.79M 2025-12
Cassava Sciences USD 7.9M 1.08M 2025-09
Cipla INR 13.25B 101.8M 2025-12
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.33M 50K 2025-09
CSL USD 1.23B 498M 2025-12
Grifols EUR 333.1M 157M 2025-09
J&J USD 6.75B 831M 2025-12
Merck USD 2.85B 215M 2025-12
Pacira USD 91.87M 70K 2025-12
Pfizer USD 4.08B 894M 2025-12
TherapeuticsMD USD 1.23M 90K 2024-06